Trade Secrets and the Art of Planned Exposure
Written by Ben Esplin
Companies building on proprietary technology routinely face a version of the same dilemma. A customer's procurement team wants architecture documentation to satisfy an internal risk review. A partner wants integration access deep enough to build a joint product. A prospective licensee wants to see "how the sausage is made" before signing. In every case, legal and business teams find themselves pulled in opposite directions: business worries that guarding the technology too closely will chill the relationship or kill the deal, while legal worries that opening the door too wide hands a partner everything it needs to build a substitute product internally and walk away. The dispute is usually framed as a fight over how much access to grant. That framing is the mistake, because it treats every disclosure as the same kind of risk.
The real distinction is not between exposure and no exposure. It is between exposure that happens to a company and exposure a company plans. Most of the disclosures that eventually cause trouble were never designed in the first place. They accumulate informally over the life of a relationship, through onboarding calls, ad hoc technical walkthroughs, and documentation shared without anyone stopping to define what was actually being given away or why. Nobody decided to disclose that information; it simply happened in the ordinary course of doing business together. Trade secret protection, properly understood, exists to prevent exactly that kind of unplanned exposure by giving the company a mechanism to convert disclosure into something deliberate, bounded, and reversible on the company's own terms.
This is where the "reasonable measures" standard under the Defend Trade Secrets Act and state trade secret statutes does more work than it is usually given credit for. The standard has never required maximal secrecy; it asks only whether the measures taken were reasonable given the circumstances of the disclosure. A carefully scoped, purpose-limited license is itself a reasonable measure, and it lets a company grant real, useful access to a partner while contractually foreclosing the specific uses it is actually worried about. In other words, the standard does not just tolerate planned exposure. It rewards it.
Planning the exposure also solves a definitional problem that has always dogged trade secret law. Standing alone, a trade secret is a legal status with famously fuzzy boundaries. Litigants often cannot say precisely what the secret is until a court forces the question through expert testimony and forensic reconstruction, well after a dispute has already started. A negotiated field-of-use restriction does that definitional work up front instead of after the fact. When a company grants a partner access to specific documentation, interfaces, or technical output for a defined purpose, and expressly prohibits use of that access to develop, market, or support a competing or substitute offering, the parties have already answered the two questions a courtroom would otherwise have to reconstruct: what was disclosed, and what the recipient was permitted to do with it. Precision about the asset and precision about the license is what actually preserves trust in the relationship; vagueness is what produces suspicion and eventual disputes.
The contractual layer does more than clarify the bargain. Because trade secret statutes do not preempt an accompanying breach of contract claim the way they preempt overlapping common-law torts, a single instance of misuse by a customer or partner can give rise to two independent theories of liability. A misappropriation claim protects the underlying know-how as a matter of statute, regardless of what the parties' contract says. A breach of contract claim protects the specific bargain the parties actually struck, independent of whether every statutory element of misappropriation can be proven. If one theory has a gap, the other still holds.
A company that structures its partner and customer relationships this way is not choosing between guarding its technology and serving its customers. It is planning, in advance, exactly what it is willing to expose, exactly what its partner is permitted to do with that exposure, and backing that plan with two separate legal hooks instead of one. None of this requires an aggressive posture toward customers or partners. It requires the opposite: specificity. A company that can say precisely what a partner is getting, and precisely what the partner may and may not do with it, will rarely need to say no to a legitimate request. It only needs to say no to the exposure it never planned to give.